Comparison of the risk of pneumothorax in COVID-19 and seasonal influenza.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
10 Sep 2024
Historique:
received: 02 06 2024
accepted: 02 08 2024
medline: 11 9 2024
pubmed: 11 9 2024
entrez: 10 9 2024
Statut: epublish

Résumé

Limited evidence exists regarding the link between coronavirus disease 2019 (COVID-19) and pneumothorax. Therefore, we aimed to evaluate the occurrence rate of pneumothorax in hospitalized patients with COVID-19 and compare the risk of pneumothorax between patients with COVID-19 and influenza. This retrospective cohort study used patient data from the National Health Insurance Service of South Korea. Patients diagnosed with COVID-19 (December 2019 to December 2021) and influenza (January 2019 to December 2021) who required hospitalization and respiratory support were included. We identified 46,460 patients with COVID-19 and 6,117 with influenza. The occurrence rate of pneumothorax was 0.74% in patients with COVID-19. In an inverse probability of treatment weighting matched cohort, the Cox proportional hazards regression model showed that COVID-19 was not associated with an increased risk of pneumothorax compared to influenza (hazard ratio, 1.22; 95% confidence interval, 0.75-1.99). However, the risk of pneumothorax associated with COVID-19 compared to influenza was significantly higher in patients without chronic lung disease than in those with (P for heterogeneity = 0.037). In conclusion, COVID-19, compared with influenza, is not associated with an increased risk of pneumothorax; however, it is associated with an increased risk in patients without chronic lung disease.

Identifiants

pubmed: 39256438
doi: 10.1038/s41598-024-69266-x
pii: 10.1038/s41598-024-69266-x
doi:

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

21077

Subventions

Organisme : National Research Foundation of Korea
ID : NRF-2021R1A5A2030333

Informations de copyright

© 2024. The Author(s).

Références

Noppen, M. & De Keukeleire, T. Pneumothorax. Respiration 76, 121–127. https://doi.org/10.1159/000135932 (2008).
doi: 10.1159/000135932 pubmed: 18708734
Johns Hopkins University & Medicine: COVID-19 Map - Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html . (Accessed 20 Mar, 2024).
Bonato, M. et al. Pneumothorax and/or Pneumomediastinum worsens the prognosis of COVID-19 patients with severe acute respiratory failure: A multicenter retrospective case-control study in the North-East of Italy. J. Clin. Med. 10, 5. https://doi.org/10.3390/jcm10214835 (2021).
doi: 10.3390/jcm10214835
Akram, J. et al. Epidemiological and outcome analysis of COVID-19-associated pneumothorax: Multicentre retrospective critical care experience from Qatar. BMJ Open 12, e053398. https://doi.org/10.1136/bmjopen-2021-053398 (2022).
doi: 10.1136/bmjopen-2021-053398 pubmed: 35190427
Ragnoli, B. et al. Pneumothorax in hospitalized COVID-19 patients with severe respiratory failure: Risk factors and outcome. Respir Med. 211, 107194. https://doi.org/10.1016/j.rmed.2023.107194 (2023).
doi: 10.1016/j.rmed.2023.107194 pubmed: 36889518 pmcid: 9987602
Belletti, A. et al. Barotrauma in coronavirus disease 2019 patients undergoing invasive mechanical ventilation: A systematic literature review. Crit. Care Med. 50, 491–500. https://doi.org/10.1097/ccm.0000000000005283 (2022).
doi: 10.1097/ccm.0000000000005283 pubmed: 34637421
Zantah, M., Dominguez Castillo, E., Townsend, R., Dikengil, F. & Criner, G. J. Pneumothorax in COVID-19 disease-incidence and clinical characteristics. Respir Res. 21, 236. https://doi.org/10.1186/s12931-020-01504-y (2020).
doi: 10.1186/s12931-020-01504-y pubmed: 32938445 pmcid: 7492794
Marciniak, S. J. et al. COVID-19 pneumothorax in the UK: A prospective observational study using the ISARIC WHO clinical characterisation protocol. Eur. Respir. J. https://doi.org/10.1183/13993003.00929-2021 (2021).
doi: 10.1183/13993003.00929-2021 pubmed: 34083401 pmcid: 8186005
Lemmers, D. H. L. et al. Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?. ERJ. Open Res. https://doi.org/10.1183/23120541.00385-2020 (2020).
doi: 10.1183/23120541.00385-2020 pubmed: 33257914 pmcid: 7537408
McGuinness, G. et al. Increased incidence of barotrauma in patients with COVID-19 on invasive mechanical ventilation. Radiology 297, E252-e262. https://doi.org/10.1148/radiol.2020202352 (2020).
doi: 10.1148/radiol.2020202352 pubmed: 32614258
Fiacchini, G. et al. Evaluation of the incidence and potential mechanisms of tracheal complications in patients with COVID-19. JAMA Otolaryngol. Head Neck Surg. 147, 70–76. https://doi.org/10.1001/jamaoto.2020.4148 (2021).
doi: 10.1001/jamaoto.2020.4148 pubmed: 33211087
Protti, A. et al. Barotrauma in mechanically ventilated patients with Coronavirus disease 2019: A survey of 38 hospitals in Lombardy, Italy. Minerva Anestesiol 87, 193–198. https://doi.org/10.23736/s0375-9393.20.15002-8 (2021).
doi: 10.23736/s0375-9393.20.15002-8 pubmed: 33325217
Knox, D. B., Brunhoeber, A., Peltan, I. D., Brown, S. M. & Lanspa, M. J. Comparison of radiographic pneumothorax and pneumomediastinum in COVID-19 vs. non-COVID-19 acute respiratory distress syndrome. Intens. Care Med. 48, 1648–1651. https://doi.org/10.1007/s00134-022-06816-9 (2022).
doi: 10.1007/s00134-022-06816-9
Guo, H. H., Sweeney, R. T., Regula, D. & Leung, A. N. Best cases from the AFIP: Fatal 2009 influenza A (H1N1) infection, complicated by acute respiratory distress syndrome and pulmonary interstitial emphysema. Radiographics 30, 327–333. https://doi.org/10.1148/rg.302095213 (2010).
doi: 10.1148/rg.302095213 pubmed: 20068001
Fahmy, O. H. et al. Is microthrombosis the main pathology in coronavirus disease 2019 severity?-A systematic review of the postmortem pathologic findings. Crit. Care Explor. 3, e0427. https://doi.org/10.1097/cce.0000000000000427 (2021).
doi: 10.1097/cce.0000000000000427 pubmed: 34036278 pmcid: 8140776
Villar, J. et al. Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial. Lancet Respir. Med. 8, 267–276. https://doi.org/10.1016/s2213-2600(19)30417-5 (2020).
doi: 10.1016/s2213-2600(19)30417-5 pubmed: 32043986
Santa Cruz, R., Villarejo, F., Irrazabal, C. & Ciapponi, A. High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 3, Cd009098. https://doi.org/10.1002/14651858.CD009098.pub3 (2021).
doi: 10.1002/14651858.CD009098.pub3 pubmed: 33784416
Miró, Ò. et al. Frequency, risk factors, clinical characteristics, and outcomes of spontaneous pneumothorax in patients with coronavirus disease 2019: A case-control, Emergency Medicine-Based Multicenter Study. Chest 159, 1241–1255. https://doi.org/10.1016/j.chest.2020.11.013 (2021).
doi: 10.1016/j.chest.2020.11.013 pubmed: 33227276
Hallifax, R. J., Goldacre, R., Landray, M. J., Rahman, N. M. & Goldacre, M. J. Trends in the incidence and recurrence of inpatient-treated spontaneous pneumothorax, 1968–2016. Jama 320, 1471–1480. https://doi.org/10.1001/jama.2018.14299 (2018).
doi: 10.1001/jama.2018.14299 pubmed: 30304427 pmcid: 6233798
Elabbadi, A. et al. Spontaneous pneumomediastinum: A surrogate of P-SILI in critically ill COVID-19 patients. Crit Care 26, 350. https://doi.org/10.1186/s13054-022-04228-1 (2022).
doi: 10.1186/s13054-022-04228-1 pubmed: 36371306 pmcid: 9652578
Cai, Z. et al. Patient self-inflicted lung injury associated pneumothorax/pneumomediastinum is a risk factor for worse outcomes of severe COVID-19: A case-control study. Sci Rep 14, 15437. https://doi.org/10.1038/s41598-024-66229-0 (2024).
doi: 10.1038/s41598-024-66229-0 pubmed: 38965293 pmcid: 11224394
Esnault, P. et al. High respiratory drive and excessive respiratory efforts predict relapse of respiratory failure in critically ill patients with COVID-19. Am. J. Respir Crit. Care Med. 202, 1173–1178. https://doi.org/10.1164/rccm.202005-1582LE (2020).
doi: 10.1164/rccm.202005-1582LE pubmed: 32755309 pmcid: 7560807
Tonelli, R. et al. Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19: A matched control study. Am J Respir Crit Care Med 204, 725–728. https://doi.org/10.1164/rccm.202104-1029LE (2021).
doi: 10.1164/rccm.202104-1029LE pubmed: 34214009 pmcid: 8521698
Weaver, L. et al. High risk of patient self-inflicted lung injury in COVID-19 with frequently encountered spontaneous breathing patterns: a computational modelling study. Ann Intensive Care 11, 109. https://doi.org/10.1186/s13613-021-00904-7 (2021).
doi: 10.1186/s13613-021-00904-7 pubmed: 34255207 pmcid: 8276227
Horby, P. et al. Dexamethasone in hospitalized patients with covid-19. N Engl J Med 384, 693–704. https://doi.org/10.1056/NEJMoa2021436 (2021).
doi: 10.1056/NEJMoa2021436 pubmed: 32678530
National Institutes of Health: COVID-19 Treatment Guidelines: Systemic Corticosteroids. https://www.covid19treatmentguidelines.nih.gov/therapies/immunomodulators/systemic-corticosteroids/ (accessed 20 Mar, 2024).
Ni, Y. N., Chen, G., Sun, J., Liang, B. M. & Liang, Z. A. The effect of corticosteroids on mortality of patients with influenza pneumonia: A systematic review and meta-analysis. Crit. Care 23, 99. https://doi.org/10.1186/s13054-019-2395-8 (2019).
doi: 10.1186/s13054-019-2395-8 pubmed: 30917856 pmcid: 6437920
Eastridge, C. E. & Hamman, J. L. Pneumothorax complicated by chronic steroid treatment. Am. J. Surg. 126, 784–787. https://doi.org/10.1016/s0002-9610(73)80071-6 (1973).
doi: 10.1016/s0002-9610(73)80071-6 pubmed: 4758799
Nishimoto, K. et al. Pneumothorax in connective tissue disease-associated interstitial lung disease. PLoS ONE 15, e0235624. https://doi.org/10.1371/journal.pone.0235624 (2020).
doi: 10.1371/journal.pone.0235624 pubmed: 32634173 pmcid: 7340294
Belletti, A. et al. Predictors of pneumothorax/pneumomediastinum in mechanically ventilated covid-19 patients. J. Cardiothorac. Vasc. Anesth. 35, 3642–3651. https://doi.org/10.1053/j.jvca.2021.02.008 (2021).
doi: 10.1053/j.jvca.2021.02.008 pubmed: 33678544 pmcid: 8054543
Kahn, M. R., Watson, R. L., Thetford, J. T., Wong, J. I. & Kamangar, N. High incidence of barotrauma in patients with severe coronavirus disease 2019. J. Intensive Care Med. 36, 646–654. https://doi.org/10.1177/0885066621989959 (2021).
doi: 10.1177/0885066621989959 pubmed: 33722090 pmcid: 7967021
National Health Insurance Service: 2021 National Health Insurance statistics. https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020045020000&brdScnBltNo=4&brdBltNo=2314&pageIndex=1&pageIndex2=1 . (Accessed 20 Mar, 2024).
Austin, P. C. & Stuart, E. A. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34, 3661–3679. https://doi.org/10.1002/sim.6607 (2015).
doi: 10.1002/sim.6607 pubmed: 26238958 pmcid: 4626409
Chesnaye, N. C. et al. An introduction to inverse probability of treatment weighting in observational research. Clin. Kidney J. 15, 14–20. https://doi.org/10.1093/ckj/sfab158 (2022).
doi: 10.1093/ckj/sfab158 pubmed: 35035932
Austin, P. C. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat. Med. 28, 3083–3107. https://doi.org/10.1002/sim.3697 (2009).
doi: 10.1002/sim.3697 pubmed: 19757444 pmcid: 3472075
Austin, P. C. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat. Med. 35, 5642–5655. https://doi.org/10.1002/sim.7084 (2016).
doi: 10.1002/sim.7084 pubmed: 27549016 pmcid: 5157758

Auteurs

Myung Jin Song (MJ)

Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, 82 Gumi-ro, Bundang-gu, Seongnam-si, 13620, Republic of Korea.

Minsun Kang (M)

Department of Preventive Medicine, Gachon University College of Medicine, 38 Dokjeom-ro 3-beon-gil, Namdong-gu, Incheon, 21565, Republic of Korea.

Kyoung-Ho Song (KH)

Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, 82 Gumi-ro, Bundang-gu, Seongnam-si, 13620, Republic of Korea.

Hong Bin Kim (HB)

Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, 82 Gumi-ro, Bundang-gu, Seongnam-si, 13620, Republic of Korea.

Eu Suk Kim (ES)

Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, 82 Gumi-ro, Bundang-gu, Seongnam-si, 13620, Republic of Korea.

Jaehun Jung (J)

Department of Preventive Medicine, Gachon University College of Medicine, 38 Dokjeom-ro 3-beon-gil, Namdong-gu, Incheon, 21565, Republic of Korea.

Sung Yoon Lim (SY)

Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, 82 Gumi-ro, Bundang-gu, Seongnam-si, 13620, Republic of Korea. nucleon727@snu.ac.kr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH